Back to search

University of Edinburgh

Restraint of Th17 differentiation by Klf2

Abstract

dc:description.abstract

Th17 cells develop naturally in vivo or can be induced in vitro. In our in vitro Th17 differentiation experiments, we found that even under appropriate conditions, a subset of cells remained IL-17A-. Interestingly, these cells showed activation and proliferation comparable to IL-17A+ cells, suggesting an endogenous mechanism restricting their differentiation. Transcriptomic analysis revealed higher Klf2 expression in IL-17A- cells. Functional assays confirmed that Klf2 negatively regulates Th17 differentiation, as Klf2 knockdown enhanced differentiation efficiency, whereas overexpression inhibited it. We further investigated this regulatory mechanism in vivo using Klf2 conditional knockout mice to understand its role in autoimmune disease. Previous studies linked Klf2 to stemness maintenance and T cell migration. Consistently, we observed migratory defects in various knockout strains, including impaired thymic egress and reduced peripheral T cells with an activated phenotype. These pronounced defects hindered in vivo Th17 functional studies, but we still detected an elevated Th17 cell population in the limited peripheral T cells, confirming Klf2’s regulatory relevance. To obtain sufficient peripheral naïve T cells with reduced Klf2, we used Klf2f/w dLckCre heterozygous mice and confirmed Klf2’s suppressive effect on Th17 differentiation. Mechanistically, integrated ATAC-seq and RNA-seq analyses showed higher expression of Irf4 and Stat3 in heterozygous cells. We then explored Klf2's role in Th17 function under pathological conditions, but migration defects in HET mice impaired Th17 infiltration into the central nervous system (CNS). Even CreERT2-mediated inducible deletion failed to bypass these issues. To overcome this and directly assess Klf2’s impact in both physiological and pathological contexts, we propose generating Klf2-overexpressing mice. In addition to genetic tools, we used small molecules to modulate Klf2 expression and investigate its role in Th17 differentiation. We found that simvastatin suppresses Th17 differentiation while upregulating Klf2. This suppressive effect is enhanced by retrovirus-mediated Klf2 overexpression but persists in Klf2 knockout cells, indicating that the regulation of Th17 cells is not entirely Klf2-dependent. Transcriptomic analysis showed that simvastatin increases Klf2 transcription and broadly affects pathways related to T cell activation and cholesterol metabolism. Future studies using Klf2 knockout cells could further elucidate Klf2-independent mechanisms underlying simvastatin’s regulation of Th17 cells, potentially expanding our understanding of Th17 regulatory pathways. In conclusion, this study highlights Klf2's crucial role in regulating Th17 cells and offers insights into its complex functions in CD4+ T cells.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Wu, Jiayan
Advisors dc:contributor.advisor
  • Lu, Linrong
  • Sloan, Richard
  • Makrantoni, Vaso
  • Brook, Matthew

Subjects

dc:subject × 3

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Wu, Jiayan. Restraint of Th17 differentiation by Klf2. 2026. https://hdl.handle.net/1842/45221